US 12398197
Antibodies with engineered CH2 domains, compositions thereof and methods of using the same
granted A61PA61P35/00A61P37/06
Quick answer
US patent 12398197 (Antibodies with engineered CH2 domains, compositions thereof and methods of using the same) held by Sutro Biopharma, Inc. expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sutro Biopharma, Inc.
- Grant date
- Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P35/00, A61P37/06